MedPath

Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women

Completed
Conditions
Breast Cancer
Interventions
Other: physiologic testing
Other: screening questionnaire administration
Procedure: breast imaging study
Procedure: radiomammography
Procedure: study of high risk factors
Registration Number
NCT00445445
Lead Sponsor
Case Comprehensive Cancer Center
Brief Summary

RATIONALE: Studying mammograms for breast density changes over time may help doctors predict breast cancer risk.

PURPOSE: This natural history study is looking at changes in breast density and gathering health information over time to assess breast cancer risk in women with breast cancer and in healthy women.

Detailed Description

OBJECTIVES:

* Characterize each woman's individual mammographic density (MD) longitudinal change trajectory in women with breast cancer and in healthy female participants to assess within-individual MD longitudinal change and breast cancer risk.

* Examine whether these patients or healthy participants manifest different patterns of within-individual change in MD and evaluate predictors of across-individual differences.

* Determine whether the developmental profile of MD differs systematically between these patients and healthy participants.

OUTLINE: This is a prospective, retrospective, controlled study. Patients and healthy participants are frequency-matched by age (± 2 years) and ethnicity.

* Questionnaire: Patients and healthy participants complete a self-administered questionnaire providing detailed information on breast cancer risk factors, including demographics, behavioral and lifestyle factors, reproductive history, family history of breast cancer, comorbidities, medication and hormone replacement therapy use, and breast cancer screening history. This information is then cross-validated with documented data abstracted from medical records to provide a longitudinal and historical framework for assessing individual risk.

* Mammographic density (MD) assessment: Patients and healthy participants are evaluated for patterns of longitudinal change in MD and subsequent breast cancer risk by retrospective review of screening mammograms performed prior to breast cancer diagnosis.

PROJECTED ACCRUAL: A total of 1500 patients and 1500 healthy participants will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
2201
Inclusion Criteria
  • Patient at the University Hospitals Breast Center and primary care clinics within the University Hospitals system
  • Have at least 3 screening mammograms since 1994
  • for cases, diagnosis with breast cancer between 2004-2006

Exclusion criteria:

  • having had irregular screening (less than 3 mammorgrams since 1994)
  • Having breast implants
  • Known carriers of BRCA1/BRCA2 genes
  • Unable to give written consent
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Healthy participantsscreening questionnaire administrationHealthy participant who is receiving routine medical care (e.g., screening mammograms. Healthy participants are frequency-matched by age (± 2 years) and ethnicity.
Healthy participantsradiomammographyHealthy participant who is receiving routine medical care (e.g., screening mammograms. Healthy participants are frequency-matched by age (± 2 years) and ethnicity.
Patientsphysiologic testingHistologically confirmed breast cancer that was diagnosed between the years 2002-2004
Patientsbreast imaging studyHistologically confirmed breast cancer that was diagnosed between the years 2002-2004
Healthy participantsbreast imaging studyHealthy participant who is receiving routine medical care (e.g., screening mammograms. Healthy participants are frequency-matched by age (± 2 years) and ethnicity.
Healthy participantsphysiologic testingHealthy participant who is receiving routine medical care (e.g., screening mammograms. Healthy participants are frequency-matched by age (± 2 years) and ethnicity.
Patientsscreening questionnaire administrationHistologically confirmed breast cancer that was diagnosed between the years 2002-2004
PatientsradiomammographyHistologically confirmed breast cancer that was diagnosed between the years 2002-2004
Patientsstudy of high risk factorsHistologically confirmed breast cancer that was diagnosed between the years 2002-2004
Healthy participantsstudy of high risk factorsHealthy participant who is receiving routine medical care (e.g., screening mammograms. Healthy participants are frequency-matched by age (± 2 years) and ethnicity.
Primary Outcome Measures
NameTimeMethod
Within-individual mammographic density (MD) longitudinal change and breast cancer riskcancer cases diagnosed within the last 3 years (2004-2006).
Patterns of within-individual longitudinal change in MDcancer cases diagnosed within the last 3 years (2004-2006)
Predictors of across-individual differences in MD changecancer cases diagnosed within the last 3 years (2004-2006)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (8)

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center

🇺🇸

Cleveland, Ohio, United States

UH-LUICC

🇺🇸

Mentor, Ohio, United States

UH-Chagrin Highlands Orange Village Ohio 44122

🇺🇸

Orange Village, Ohio, United States

UH-Monarch

🇺🇸

Mayfield Heights, Ohio, United States

UH-Southwest

🇺🇸

Middleburg Heights, Ohio, United States

UH-Firelands

🇺🇸

Sandusky, Ohio, United States

UH-Green Road

🇺🇸

South Euclid, Ohio, United States

UH-Westlake

🇺🇸

Westlake, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath